Literature DB >> 15796126

Specific genetic disorders and autism: clinical contribution towards their identification.

David Cohen1, Nadège Pichard, Sylvie Tordjman, Clarisse Baumann, Lydie Burglen, Elsa Excoffier, Gabriela Lazar, Philippe Mazet, Clément Pinquier, Alain Verloes, Delphine Héron.   

Abstract

Autism is a heterogeneous disorder that can reveal a specific genetic disease. This paper describes several genetic diseases consistently associated with autism (fragile X, tuberous sclerosis, Angelman syndrome, duplication of 15q11-q13, Down syndrome, San Filippo syndrome, MECP2 related disorders, phenylketonuria, Smith-Magenis syndrome, 22q13 deletion, adenylosuccinate lyase deficiency, Cohen syndrome, and Smith-Lemli-Opitz syndrome) and proposes a consensual and economic diagnostic strategy to help practitioners to identify them. A rigorous initial clinical screening is presented to avoid unnecessary laboratory and imaging studies. Regarding psychiatric nosography, the concept of "syndromal autism"--autism associated with other clinical signs should be promoted because it may help to distinguish patients who warrant a multidisciplinary approach and further investigation.

Entities:  

Mesh:

Year:  2005        PMID: 15796126     DOI: 10.1007/s10803-004-1038-2

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  96 in total

1.  X-linked mental retardation with marfanoid habitus.

Authors:  J P Fryns
Journal:  Am J Med Genet       Date:  1991 Feb-Mar

2.  The value of investigation for genetic counselling in tuberous sclerosis.

Authors:  A E Fryer; A H Chalmers; J P Osborne
Journal:  J Med Genet       Date:  1990-04       Impact factor: 6.318

3.  Behavioral phenotypes: conceptual and methodological issues.

Authors:  J Flint
Journal:  Am J Med Genet       Date:  1998-05-08

4.  Smith-Lemli-Opitz syndrome-type II: multiple congenital anomalies with male pseudohermaphroditism and frequent early lethality.

Authors:  C J Curry; J C Carey; J S Holland; D Chopra; R Fineman; M Golabi; S Sherman; R A Pagon; J Allanson; S Shulman
Journal:  Am J Med Genet       Date:  1987-01

Review 5.  Behaviour problems in Angelman syndrome.

Authors:  J A Summers; D B Allison; P S Lynch; L Sandler
Journal:  J Intellect Disabil Res       Date:  1995-04

Review 6.  Mental retardation: genetic findings, clinical implications and research agenda.

Authors:  E Simonoff; P Bolton; M Rutter
Journal:  J Child Psychol Psychiatry       Date:  1996-03       Impact factor: 8.982

7.  Autism in Angelman syndrome: a population-based study.

Authors:  S Steffenburg; C L Gillberg; U Steffenburg; M Kyllerman
Journal:  Pediatr Neurol       Date:  1996-02       Impact factor: 3.372

8.  Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location.

Authors:  J P Cheadle; H Gill; N Fleming; J Maynard; A Kerr; H Leonard; M Krawczak; D N Cooper; S Lynch; N Thomas; H Hughes; M Hulten; D Ravine; J R Sampson; A Clarke
Journal:  Hum Mol Genet       Date:  2000-04-12       Impact factor: 6.150

9.  Absence of MeCP2 mutations in patients from the South Carolina autism project.

Authors:  Fe Lobo-Menendez; Khalid Sossey-Alaoui; Jennifer M Bell; Susan A Copeland-Yates; Sara M Plank; Stewart O Sanford; Cindy Skinner; Richard J Simensen; Richard J Schroer; Ron C Michaelis
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2003-02       Impact factor: 3.568

Review 10.  Autism and medical disorders: a review of the literature.

Authors:  C Gillberg; M Coleman
Journal:  Dev Med Child Neurol       Date:  1996-03       Impact factor: 5.449

View more
  96 in total

1.  A comparison of pragmatic language in boys with autism and fragile X syndrome.

Authors:  Jessica Klusek; Gary E Martin; Molly Losh
Journal:  J Speech Lang Hear Res       Date:  2014-10       Impact factor: 2.297

Review 2.  The genetics of autism spectrum disorders.

Authors:  Dorothy E Grice; Joseph D Buxbaum
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 3.  The fragile X mental retardation protein in circadian rhythmicity and memory consolidation.

Authors:  Cheryl L Gatto; Kendal Broadie
Journal:  Mol Neurobiol       Date:  2009-02-12       Impact factor: 5.590

4.  Autism Symptomatology in Boys with Fragile X Syndrome: A Cross Sectional Developmental Trajectories Comparison with Nonsyndromic Autism Spectrum Disorder.

Authors:  Angela John Thurman; Andrea McDuffie; Sara T Kover; Randi J Hagerman; Leonard Abbeduto
Journal:  J Autism Dev Disord       Date:  2015-09

5.  Brief Report: Syndromes in Autistic Children in a Finnish Birth Cohort.

Authors:  Laura Timonen-Soivio; Raija Vanhala; Heli Malm; Susanna Hinkka-Yli-Salomäki; Mika Gissler; Alan Brown; Andre Sourander
Journal:  J Autism Dev Disord       Date:  2016-08

6.  Acquired autistic behaviors in children with mucopolysaccharidosis type IIIA.

Authors:  Robin K Rumsey; Kyle Rudser; Kathleen Delaney; Michael Potegal; Chester B Whitley; Elsa Shapiro
Journal:  J Pediatr       Date:  2014-02-25       Impact factor: 4.406

7.  Physiological arousal in autism and fragile X syndrome: group comparisons and links with pragmatic language.

Authors:  Jessica Klusek; Gary E Martin; Molly Losh
Journal:  Am J Intellect Dev Disabil       Date:  2013-11

8.  Alterations in sociability and functional brain connectivity caused by early-life seizures are prevented by bumetanide.

Authors:  Gregory L Holmes; Chengju Tian; Amanda E Hernan; Sean Flynn; Devon Camp; Jeremy Barry
Journal:  Neurobiol Dis       Date:  2015-03-10       Impact factor: 5.996

9.  The Neurobiological Basis for Social Affiliation in Autism Spectrum Disorder and Schizophrenia.

Authors:  Amanda Crider; Anilkumar Pillai
Journal:  Curr Behav Neurosci Rep       Date:  2016-04-16

10.  Autism spectrum disorder in fragile X syndrome: a longitudinal evaluation.

Authors:  R Nick Hernandez; Rachel L Feinberg; Rebecca Vaurio; Natalie M Passanante; Richard E Thompson; Walter E Kaufmann
Journal:  Am J Med Genet A       Date:  2009-06       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.